BIORA THERAPEUTICS INC - NOTE 7.250%12/0

CUSIP: 74319FAB3

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Debt / NOTE 7.250%12/0
Market price (% of par)
53.56%
Total 13F principal
$128,527,200
Principal change
$0
Total reported market value
$71,400,554
Number of holders
6

Quarterly Holders Quick Answers

What is CUSIP 74319FAB3?
CUSIP 74319FAB3 identifies 74319FAB3 - BIORA THERAPEUTICS INC - NOTE 7.250%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIORA THERAPEUTICS INC - NOTE 7.250%12/0 as of Q4 2022

As of 31 Dec 2022, BIORA THERAPEUTICS INC - NOTE 7.250%12/0 was held by 6 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $128,527,200 in principal (par value) of the bond. The largest 6 bondholders included Athyrium Capital Management, LP, Davidson Kempner Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, CAMDEN ASSET MANAGEMENT L P /CA, SILVERBACK ASSET MANAGEMENT LLC, and Context Capital Management, LLC. This page lists 6 institutional bondholders reporting positions for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.